Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical Trial A Second Pivotal…
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical Trial A Second Pivotal…
GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) — In a bold move to democratize access…
804 Alzheimer’s Patients Are Enrolled in a Pivotal Phase 3 Clinical Trial A Second Pivotal…
GOLDEN, Colo., Oct. 02, 2023 (GLOBE NEWSWIRE) — In a bold move to democratize access…
– Bipartisan resolution highlights the challenges patients with rare cancers face and raises awareness and…
NEW YORK, Oct. 02, 2023 (GLOBE NEWSWIRE) — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the…
Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform…
The Cyberdome uses Stellar Cyber’s Open XDR platform to bring free, world-class cybersecurity services to…
Refinancing of Current $400M Debt at Lower Cost and Improved Amortization Schedule Blackstone to also…
Rogers tests 5G network on TTC with Toronto Maple Leafs Defenceman Morgan Rielly Company develops…
Adopting a .CA domain name signals that a business is closely tied to its local…
Toronto, Ontario–(Newsfile Corp. – October 2, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Vancouver, British Columbia–(Newsfile Corp. – October 2, 2023) – Fandifi Technology Corp. (CSE: FDM) (OTC…
TOKYO, Oct 2, 2023 – (JCN Newswire) – FGSS modules TOKYO, Oct 2, 2023 –…
TOKYO, Oct 2, 2023 – (JCN Newswire) – Conceptual drawing of the new Abukuma Clean…
LONDON, Oct 2, 2023 – (ACN Newswire) – Aiming at fostering investment in the green…
Transaction marks next chapter for Forcepoint G2CI as a standalone company backed by leading technology…
Based on pioneering research from Mayo Clinic, ECG-AI LEF aims to aid physicians in identifying…
C-suite veteran brings expertise scaling new technologies and executing capital markets strategies to accelerate business…
Appointment comes as BPGbio plans for late-stage trials in oncology and rare disease Dr. Modur…